Which has stronger earnings and valuation, MDT or DXCM?

Medtronic has higher revenue and earnings than DexCom. Medtronic is trading at a lower price-to-earnings ratio than DexCom, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Medtronic $36.36B 2.80 $4.80B $3.73 21.28 DexCom $4.66B 6.00 $836.30M $2.34 30.97

Is MDT or DXCM more profitable?

DexCom has a net margin of 19.31% compared to Medtronic's net margin of 13.20%. DexCom's return on equity of 33.33% beat Medtronic's return on equity. Company Net Margins Return on Equity Return on Assets Medtronic 13.20% 14.61% 7.80% DexCom 19.31% 33.33% 13.19%

Does the media refer more to MDT or DXCM?

In the previous week, Medtronic had 18 more articles in the media than DexCom. MarketBeat recorded 41 mentions for Medtronic and 23 mentions for DexCom. Medtronic's average media sentiment score of 1.23 beat DexCom's score of 1.14 indicating that Medtronic is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Medtronic 33 Very Positive mention(s) 3 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Positive DexCom 17 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer GEHC or MDT?

In the previous week, Medtronic had 28 more articles in the media than GE HealthCare Technologies. MarketBeat recorded 41 mentions for Medtronic and 13 mentions for GE HealthCare Technologies. GE HealthCare Technologies' average media sentiment score of 1.41 beat Medtronic's score of 1.23 indicating that GE HealthCare Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment GE HealthCare Technologies 12 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Medtronic 33 Very Positive mention(s) 3 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Positive

Does the media prefer ISRG or MDT?

In the previous week, Intuitive Surgical had 29 more articles in the media than Medtronic. MarketBeat recorded 70 mentions for Intuitive Surgical and 41 mentions for Medtronic. Intuitive Surgical's average media sentiment score of 1.51 beat Medtronic's score of 1.23 indicating that Intuitive Surgical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Intuitive Surgical 65 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Very Positive Medtronic 33 Very Positive mention(s) 3 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Positive

Does the media refer more to MDT or ABT?

In the previous week, Abbott Laboratories had 14 more articles in the media than Medtronic. MarketBeat recorded 55 mentions for Abbott Laboratories and 41 mentions for Medtronic. Abbott Laboratories' average media sentiment score of 1.53 beat Medtronic's score of 1.23 indicating that Abbott Laboratories is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Medtronic 33 Very Positive mention(s) 3 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Positive Abbott Laboratories 50 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Does the media prefer BSX or MDT?

In the previous week, Boston Scientific had 9 more articles in the media than Medtronic. MarketBeat recorded 50 mentions for Boston Scientific and 41 mentions for Medtronic. Boston Scientific's average media sentiment score of 1.51 beat Medtronic's score of 1.23 indicating that Boston Scientific is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Boston Scientific 46 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Very Positive Medtronic 33 Very Positive mention(s) 3 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Positive

Medtronic (MDT) Competitors

$79.37 +0.03 (+0.03%)

Closing price 06/18/2026 03:59 PM Eastern

Extended Trading

$79.40 +0.03 (+0.04%)

As of 06/18/2026 07:45 PM Eastern

Compare

MDT vs. DXCM, GEHC, ISRG, ABT, and BSX

Should you buy Medtronic stock or one of its competitors? MarketBeat compares Medtronic with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Medtronic include DexCom (DXCM), GE HealthCare Technologies (GEHC), Intuitive Surgical (ISRG), Abbott Laboratories (ABT), and Boston Scientific (BSX). These companies are all part of the "medical" sector.

How does Medtronic compare to DexCom?

Medtronic (NYSE:MDT) and DexCom (NASDAQ:DXCM) are both large-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, risk, institutional ownership, dividends, analyst recommendations, valuation, earnings and media sentiment.

In the previous week, Medtronic had 18 more articles in the media than DexCom. MarketBeat recorded 41 mentions for Medtronic and 23 mentions for DexCom. Medtronic's average media sentiment score of 1.23 beat DexCom's score of 1.14 indicating that Medtronic is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Medtronic	33 Very Positive mention(s)	3 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Positive
DexCom	17 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Medtronic presently has a consensus price target of $99.00, suggesting a potential upside of 24.74%. DexCom has a consensus price target of $84.83, suggesting a potential upside of 17.06%. Given Medtronic's higher probable upside, equities research analysts clearly believe Medtronic is more favorable than DexCom.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Medtronic	0 Sell rating(s)	11 Hold rating(s)	17 Buy rating(s)	0 Strong Buy rating(s)	2.61
DexCom	1 Sell rating(s)	3 Hold rating(s)	19 Buy rating(s)	3 Strong Buy rating(s)	2.92

DexCom has a net margin of 19.31% compared to Medtronic's net margin of 13.20%. DexCom's return on equity of 33.33% beat Medtronic's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Medtronic	13.20%	14.61%	7.80%
DexCom	19.31%	33.33%	13.19%

82.1% of Medtronic shares are held by institutional investors. Comparatively, 97.8% of DexCom shares are held by institutional investors. 0.3% of Medtronic shares are held by company insiders. Comparatively, 0.3% of DexCom shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Medtronic has a beta of 0.58, meaning that its share price is 42% less volatile than the broader market. Comparatively, DexCom has a beta of 1.45, meaning that its share price is 45% more volatile than the broader market.

Medtronic has higher revenue and earnings than DexCom. Medtronic is trading at a lower price-to-earnings ratio than DexCom, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Medtronic	$36.36B	2.80	$4.80B	$3.73	21.28
DexCom	$4.66B	6.00	$836.30M	$2.34	30.97

Summary

DexCom beats Medtronic on 11 of the 17 factors compared between the two stocks.

How does Medtronic compare to GE HealthCare Technologies?

GE HealthCare Technologies (NASDAQ:GEHC) and Medtronic (NYSE:MDT) are both large-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, dividends, media sentiment, earnings, profitability, analyst recommendations, valuation and risk.

GE HealthCare Technologies pays an annual dividend of $0.14 per share and has a dividend yield of 0.2%. Medtronic pays an annual dividend of $2.84 per share and has a dividend yield of 3.6%. GE HealthCare Technologies pays out 3.3% of its earnings in the form of a dividend. Medtronic pays out 76.1% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. GE HealthCare Technologies has increased its dividend for 1 consecutive years and Medtronic has increased its dividend for 49 consecutive years. Medtronic is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Medtronic has higher revenue and earnings than GE HealthCare Technologies. GE HealthCare Technologies is trading at a lower price-to-earnings ratio than Medtronic, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
GE HealthCare Technologies	$20.63B	1.36	$2.08B	$4.18	14.73
Medtronic	$36.36B	2.80	$4.80B	$3.73	21.28

82.1% of GE HealthCare Technologies shares are owned by institutional investors. Comparatively, 82.1% of Medtronic shares are owned by institutional investors. 0.4% of GE HealthCare Technologies shares are owned by company insiders. Comparatively, 0.3% of Medtronic shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Medtronic has a net margin of 13.20% compared to GE HealthCare Technologies' net margin of 9.10%. GE HealthCare Technologies' return on equity of 20.46% beat Medtronic's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
GE HealthCare Technologies	9.10%	20.46%	5.73%
Medtronic	13.20%	14.61%	7.80%

GE HealthCare Technologies currently has a consensus price target of $80.21, suggesting a potential upside of 30.23%. Medtronic has a consensus price target of $99.00, suggesting a potential upside of 24.74%. Given GE HealthCare Technologies' higher possible upside, equities research analysts clearly believe GE HealthCare Technologies is more favorable than Medtronic.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
GE HealthCare Technologies	0 Sell rating(s)	9 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.50
Medtronic	0 Sell rating(s)	11 Hold rating(s)	17 Buy rating(s)	0 Strong Buy rating(s)	2.61

GE HealthCare Technologies has a beta of 0.74, suggesting that its stock price is 26% less volatile than the broader market. Comparatively, Medtronic has a beta of 0.58, suggesting that its stock price is 42% less volatile than the broader market.

In the previous week, Medtronic had 28 more articles in the media than GE HealthCare Technologies. MarketBeat recorded 41 mentions for Medtronic and 13 mentions for GE HealthCare Technologies. GE HealthCare Technologies' average media sentiment score of 1.41 beat Medtronic's score of 1.23 indicating that GE HealthCare Technologies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
GE HealthCare Technologies	12 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Medtronic	33 Very Positive mention(s)	3 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Positive

Summary

Medtronic beats GE HealthCare Technologies on 11 of the 18 factors compared between the two stocks.

How does Medtronic compare to Intuitive Surgical?

Intuitive Surgical (NASDAQ:ISRG) and Medtronic (NYSE:MDT) are both large-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, earnings, media sentiment, profitability, analyst recommendations, institutional ownership, valuation and dividends.

Intuitive Surgical presently has a consensus target price of $573.42, indicating a potential upside of 40.96%. Medtronic has a consensus target price of $99.00, indicating a potential upside of 24.74%. Given Intuitive Surgical's stronger consensus rating and higher possible upside, equities research analysts plainly believe Intuitive Surgical is more favorable than Medtronic.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Intuitive Surgical	1 Sell rating(s)	7 Hold rating(s)	19 Buy rating(s)	0 Strong Buy rating(s)	2.67
Medtronic	0 Sell rating(s)	11 Hold rating(s)	17 Buy rating(s)	0 Strong Buy rating(s)	2.61

Intuitive Surgical has a beta of 1.46, indicating that its share price is 46% more volatile than the broader market. Comparatively, Medtronic has a beta of 0.58, indicating that its share price is 42% less volatile than the broader market.

83.6% of Intuitive Surgical shares are owned by institutional investors. Comparatively, 82.1% of Medtronic shares are owned by institutional investors. 0.6% of Intuitive Surgical shares are owned by insiders. Comparatively, 0.3% of Medtronic shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

In the previous week, Intuitive Surgical had 29 more articles in the media than Medtronic. MarketBeat recorded 70 mentions for Intuitive Surgical and 41 mentions for Medtronic. Intuitive Surgical's average media sentiment score of 1.51 beat Medtronic's score of 1.23 indicating that Intuitive Surgical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Intuitive Surgical	65 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Medtronic	33 Very Positive mention(s)	3 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Positive

Intuitive Surgical has a net margin of 28.15% compared to Medtronic's net margin of 13.20%. Intuitive Surgical's return on equity of 15.98% beat Medtronic's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Intuitive Surgical	28.15%	15.98%	14.07%
Medtronic	13.20%	14.61%	7.80%

Medtronic has higher revenue and earnings than Intuitive Surgical. Medtronic is trading at a lower price-to-earnings ratio than Intuitive Surgical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Intuitive Surgical	$10.06B	14.31	$2.86B	$8.25	49.31
Medtronic	$36.36B	2.80	$4.80B	$3.73	21.28

Summary

Intuitive Surgical beats Medtronic on 14 of the 16 factors compared between the two stocks.

How does Medtronic compare to Abbott Laboratories?

Medtronic (NYSE:MDT) and Abbott Laboratories (NYSE:ABT) are both large-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, risk, analyst recommendations, media sentiment, dividends, profitability, valuation and earnings.

Abbott Laboratories has higher revenue and earnings than Medtronic. Medtronic is trading at a lower price-to-earnings ratio than Abbott Laboratories, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Medtronic	$36.36B	2.80	$4.80B	$3.73	21.28
Abbott Laboratories	$44.33B	3.48	$6.52B	$3.57	24.78

Abbott Laboratories has a net margin of 13.90% compared to Medtronic's net margin of 13.20%. Abbott Laboratories' return on equity of 17.62% beat Medtronic's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Medtronic	13.20%	14.61%	7.80%
Abbott Laboratories	13.90%	17.62%	10.01%

Medtronic presently has a consensus target price of $99.00, suggesting a potential upside of 24.74%. Abbott Laboratories has a consensus target price of $118.30, suggesting a potential upside of 33.71%. Given Abbott Laboratories' stronger consensus rating and higher probable upside, analysts plainly believe Abbott Laboratories is more favorable than Medtronic.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Medtronic	0 Sell rating(s)	11 Hold rating(s)	17 Buy rating(s)	0 Strong Buy rating(s)	2.61
Abbott Laboratories	1 Sell rating(s)	4 Hold rating(s)	19 Buy rating(s)	2 Strong Buy rating(s)	2.85

82.1% of Medtronic shares are owned by institutional investors. Comparatively, 75.2% of Abbott Laboratories shares are owned by institutional investors. 0.3% of Medtronic shares are owned by company insiders. Comparatively, 0.5% of Abbott Laboratories shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Medtronic pays an annual dividend of $2.84 per share and has a dividend yield of 3.6%. Abbott Laboratories pays an annual dividend of $2.52 per share and has a dividend yield of 2.8%. Medtronic pays out 76.1% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Abbott Laboratories pays out 70.6% of its earnings in the form of a dividend. Medtronic has raised its dividend for 49 consecutive years and Abbott Laboratories has raised its dividend for 54 consecutive years.

Medtronic has a beta of 0.58, suggesting that its share price is 42% less volatile than the broader market. Comparatively, Abbott Laboratories has a beta of 0.63, suggesting that its share price is 37% less volatile than the broader market.

In the previous week, Abbott Laboratories had 14 more articles in the media than Medtronic. MarketBeat recorded 55 mentions for Abbott Laboratories and 41 mentions for Medtronic. Abbott Laboratories' average media sentiment score of 1.53 beat Medtronic's score of 1.23 indicating that Abbott Laboratories is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Medtronic	33 Very Positive mention(s)	3 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Positive
Abbott Laboratories	50 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Summary

Abbott Laboratories beats Medtronic on 17 of the 20 factors compared between the two stocks.

How does Medtronic compare to Boston Scientific?

Boston Scientific (NYSE:BSX) and Medtronic (NYSE:MDT) are both large-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, risk, analyst recommendations, media sentiment, profitability, institutional ownership, earnings and valuation.

Boston Scientific currently has a consensus price target of $85.08, indicating a potential upside of 87.81%. Medtronic has a consensus price target of $99.00, indicating a potential upside of 24.74%. Given Boston Scientific's stronger consensus rating and higher probable upside, equities analysts plainly believe Boston Scientific is more favorable than Medtronic.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Boston Scientific	1 Sell rating(s)	5 Hold rating(s)	23 Buy rating(s)	1 Strong Buy rating(s)	2.80
Medtronic	0 Sell rating(s)	11 Hold rating(s)	17 Buy rating(s)	0 Strong Buy rating(s)	2.61

Boston Scientific has a beta of 0.56, meaning that its stock price is 44% less volatile than the broader market. Comparatively, Medtronic has a beta of 0.58, meaning that its stock price is 42% less volatile than the broader market.

In the previous week, Boston Scientific had 9 more articles in the media than Medtronic. MarketBeat recorded 50 mentions for Boston Scientific and 41 mentions for Medtronic. Boston Scientific's average media sentiment score of 1.51 beat Medtronic's score of 1.23 indicating that Boston Scientific is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Boston Scientific	46 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Very Positive
Medtronic	33 Very Positive mention(s)	3 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Positive

Medtronic has higher revenue and earnings than Boston Scientific. Boston Scientific is trading at a lower price-to-earnings ratio than Medtronic, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Boston Scientific	$20.07B	3.35	$2.90B	$2.39	18.95
Medtronic	$36.36B	2.80	$4.80B	$3.73	21.28

89.1% of Boston Scientific shares are owned by institutional investors. Comparatively, 82.1% of Medtronic shares are owned by institutional investors. 0.3% of Boston Scientific shares are owned by insiders. Comparatively, 0.3% of Medtronic shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Boston Scientific has a net margin of 17.29% compared to Medtronic's net margin of 13.20%. Boston Scientific's return on equity of 19.17% beat Medtronic's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Boston Scientific	17.29%	19.17%	10.77%
Medtronic	13.20%	14.61%	7.80%

Summary

Boston Scientific beats Medtronic on 12 of the 17 factors compared between the two stocks.

Get Medtronic News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MDT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

MDT vs. The Competition

Export

Metric	Medtronic	MED PRODUCTS Industry	Medical Sector	NYSE Exchange
Market Cap	$101.86B	$8.34B	$6.43B	$23.21B
Dividend Yield	3.58%	2.55%	2.68%	4.06%
P/E Ratio	21.28	15.57	24.75	31.61
Price / Sales	2.80	7.37	529.99	112.15
Price / Cash	10.11	17.05	45.07	24.44
Price / Book	2.11	3.28	10.80	4.68
Net Income	$4.80B	$224.06M	$3.57B	$1.08B
7 Day Performance	-0.93%	-1.92%	0.72%	-0.82%
1 Month Performance	1.60%	-2.90%	0.41%	1.07%
1 Year Performance	-8.03%	0.83%	29.34%	25.02%

Medtronic Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
MDT Medtronic	4.9424 of 5 stars	$79.37 +0.0%	$99.00 +24.7%	-8.0%	$101.86B	$36.36B	21.28	95,000	Positive News Analyst Forecast
DXCM DexCom	4.5793 of 5 stars	$74.20 -1.5%	$84.83 +14.3%	-9.4%	$28.63B	$4.82B	31.71	11,000	Positive News Insider Trade
GEHC GE HealthCare Technologies	4.9354 of 5 stars	$64.67 -0.8%	$80.21 +24.0%	-13.6%	$29.42B	$20.98B	15.47	54,000	Positive News
ISRG Intuitive Surgical	4.3099 of 5 stars	$416.40 +1.3%	$571.28 +37.2%	-20.1%	$147.47B	$10.06B	50.47	17,021	Positive News
ABT Abbott Laboratories	4.9903 of 5 stars	$88.76 +0.7%	$118.38 +33.4%	-33.4%	$154.60B	$45.13B	24.86	115,000	Positive News Dividend Announcement Analyst Downgrade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:MDT) was last updated on 6/21/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Medtronic (MDT) Competitors

MDT vs. DXCM, GEHC, ISRG, ABT, and BSX

How does Medtronic compare to DexCom?

Summary

How does Medtronic compare to GE HealthCare Technologies?

Summary

How does Medtronic compare to Intuitive Surgical?

Summary

How does Medtronic compare to Abbott Laboratories?

Summary

How does Medtronic compare to Boston Scientific?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MDT vs. The Competition

Medtronic Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Medtronic (MDT) Competitors

MDT vs. DXCM, GEHC, ISRG, ABT, and BSX

How does Medtronic compare to DexCom?

Does the media refer more to MDT or DXCM?

Do analysts recommend MDT or DXCM?

Is MDT or DXCM more profitable?

Do insiders & institutionals have more ownership in MDT or DXCM?

Which has more volatility and risk, MDT or DXCM?

Which has stronger earnings and valuation, MDT or DXCM?

Summary

How does Medtronic compare to GE HealthCare Technologies?

Is GEHC or MDT a better dividend stock?

Which has better valuation and earnings, GEHC or MDT?

Do institutionals and insiders hold more shares of GEHC or MDT?

Is GEHC or MDT more profitable?

Do analysts rate GEHC or MDT?

Which has more risk & volatility, GEHC or MDT?

Does the media prefer GEHC or MDT?

Summary

How does Medtronic compare to Intuitive Surgical?

Do analysts recommend ISRG or MDT?

Which has more risk and volatility, ISRG or MDT?

Do insiders and institutionals believe in ISRG or MDT?

Does the media prefer ISRG or MDT?

Is ISRG or MDT more profitable?

Which has higher valuation & earnings, ISRG or MDT?

Summary

How does Medtronic compare to Abbott Laboratories?

Which has higher earnings and valuation, MDT or ABT?

Is MDT or ABT more profitable?

Do analysts rate MDT or ABT?

Do institutionals & insiders have more ownership in MDT or ABT?

Is MDT or ABT a better dividend stock?

Which has more risk and volatility, MDT or ABT?

Does the media refer more to MDT or ABT?

Summary

How does Medtronic compare to Boston Scientific?

Do analysts rate BSX or MDT?

Which has more volatility and risk, BSX or MDT?

Does the media prefer BSX or MDT?

Which has preferable earnings & valuation, BSX or MDT?

Do insiders and institutionals believe in BSX or MDT?

Is BSX or MDT more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MDT vs. The Competition

Medtronic Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools